Similar articles for PMID: 18272623

Year	Number of Results
2006	4
2007	21
2008	24
2009	15
2010	7
2011	7
2012	5
2013	2
2014	4
2015	3
2016	2
2017	5
2018	2
2019	2
2020	5
2021	16
2022	20
2023	4
2024	0

1

Do you approve of spending $300 million on HPV vaccination?: no.

Lippman A, Boscoe M, Scurfield C. Lippman A, et al. Can Fam Physician. 2008 Feb;54(2):175, 177, 179, 181. Can Fam Physician. 2008. PMID: 18272623 Free PMC article. No abstract available.

2

Rebuttal: Do you approve of spending $300 million on HPV vaccination? Yes.

Steben M. Steben M. Can Fam Physician. 2008 Mar;54(3):342, 344. Can Fam Physician. 2008. PMID: 18337521 Free PMC article. No abstract available.

3

Do you approve of spending $300 million on HPV vaccination?: yes.

Steben M. Steben M. Can Fam Physician. 2008 Feb;54(2):174, 176, 178, 180. Can Fam Physician. 2008. PMID: 18272622 Free PMC article. No abstract available.

4

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Markowitz LE, et al. MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24. MMWR Recomm Rep. 2007. PMID: 17380109 Free article.

5

The quadrivalent human papillomavirus vaccine: potential factors in effectiveness.

Zonfrillo NJ, Hackley B. Zonfrillo NJ, et al. J Midwifery Womens Health. 2008 May-Jun;53(3):188-194. doi: 10.1016/j.jmwh.2007.12.015. J Midwifery Womens Health. 2008. PMID: 18455092 Review.

6

Rebuttal: Do you approve of spending $300 million on HPV vaccination? No.

Lippman A, Boscoe M, Scurfield C. Lippman A, et al. Can Fam Physician. 2008 Mar;54(3):343, 345. Can Fam Physician. 2008. PMID: 18337522 Free PMC article. No abstract available.

7

Mandating HPV vaccination: what are the arguments?

Smith CM. Smith CM. J Christ Nurs. 2008 Apr-Jun;25(2):74-80; quiz 81-2. doi: 10.1097/01.cnj.0000314582.74158.75. J Christ Nurs. 2008. PMID: 18401926 Review. No abstract available.

8

For debate: that Australia should continue using the quadrivalent vaccine.

Wain G. Wain G. Sex Health. 2010 Sep;7(3):235-7. doi: 10.1071/sh09129. Sex Health. 2010. PMID: 21058496 No abstract available.

9

[Cytology and DNA HPV-testing in the era of HPV-vaccine].

Spaczyński M, Malkowska-Walczak B, Nowak-Markwitz E. Spaczyński M, et al. Ginekol Pol. 2007 Sep;78(9):696-700. Ginekol Pol. 2007. PMID: 18159823 Polish.

10

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.

Muñoz N, Manalastas R Jr, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J, Taddeo FJ, Esser MT, Vuocolo S, Haupt RM, Barr E, Saah A. Muñoz N, et al. Lancet. 2009 Jun 6;373(9679):1949-57. doi: 10.1016/S0140-6736(09)60691-7. Epub 2009 Jun 1. Lancet. 2009. PMID: 19493565 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

135 results

Results by year